• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Markets in Q3: Bears in the China shop

September 30, 2021 by David Barret Leave a Comment

September 30, 2021

By Marc Jones and Julien Ponthus

LONDON (Reuters) – Some of the heaviest falls ever seen in China’s markets, huge energy price rises and the clearest signs yet that central banks are starting to turn off the money taps have all hit world markets over the last quarter.

A regulatory crackdown in China has wiped a trillion dollars off its markets and sent giants such as Alibaba tumbling 30% in their worst quarter on record, while property firm Evergrande, one of the world’s biggest high-yield debt issuers, is on the brink of default.

World stocks meanwhile are headed for their first quarter of losses since COVID-19 began to take its toll early last year, bonds have had a shaky September amid taper talk, and the safe-haven dollar is gunning for its best year since 2015.

At the same time, inflation is gathering pace on the back of rising commodity and shipping costs. Natural gas is up nearly 60% since July and 120% this year, coffee is up 25% for the second quarter in a row and freight costs have risen another 40%.

Emmanuel Cau, head of European equities at Barclays, reckons markets are pricing the end of the ‘Goldilocks’ scenario – when growth and inflation are neither too high nor too low – so investors should be aware of the bears.

“The end of Q3 is somewhat a foretaste of what’s to come with central banks starting to shift policies,” Cau said, noting a “brutal regime change” as investors switch from sectors such as tech into so-called value shares such as banks and energy.

“One also needs to take into account that Chinese growth will be weaker moving forward.”

For a graphic on Global markets in 2021 and Q3:

https://ift.tt/2Y3MNOg

CHINA SMASHED

The biggest drama was in Chinese markets where a crackdown on tech, digital and for-profit education firms deepened, followed by the Evergrande meltdown.

It all added up to a near trillion-dollar slide in Chinese equities, a 70% slump in Evergrande shares and a 14% bashing for anyone invested in high-yield Chinese corporate debt.

China’s worries meant MSCI’s emerging equity index dropped almost 10% after five quarters of gains and its underperformance versus Wall Street has been an eye-watering 30 percentage points.

“This has been one of the most value-destructive periods for Chinese equity markets in history,” said William Mileham at Swiss-based asset manager Mirabaud, adding that it felt like the regulatory pressures might not end.

For a graphic on China’s stocks slammed by clampdowns:

https://ift.tt/3D25zoq

The rising dollar also complicated life for other emerging markets, with the Chilean, Brazilian and Peruvian currencies down 7% to 9% over the quarter.

Turkey’s lira lost more ground after a recent surprise interest rate cut, remaining the year’s worst performer.

For a graphic on China’s high market market pounded by Evergrande default worries:

https://ift.tt/3oqvlib

STOCKS SPLICED

World stock markets are ending the quarter in disorderly fashion, with MSCI’s global index down around 1%, its first quarterly first loss since early 2020.

Pandemic plays Zoom and Peloton have lost about a third of their value, but vaccine makers Moderna and Pfizer are up 60% and 11% respectively, and aeroplane engine maker Rolls Royce has soared over 40%.

For many investors, September will likely be remembered as the end of a financial fairy tale when fiscal and monetary stimulus combined with buoyant growth and moderate inflation relentlessly kept pushing stock prices to record highs.

Rising yields have already prompted a brutal rotation within equity portfolios as managers typically dumped growth and tech stocks for cheaper shares in the banking and oil and gas industries.

The Nasdaq came off 2% over the quarter but lost about 4.5% in September as sell-side analysts encouraged their clients to go for “value” and cut risk out of FAANGS. Even Amazon has lost ground.

“It is a very, very challenging time to build a portfolio”, said Roland Kaloyan, who heads Societe Generale’s European equity strategy.

“At the same time you want to have exposure to rising yields, hedge against rising yields and hedge your portfolio against slowing growth in China”.

For a graphic on MSCI Value vs Growth and Bund yields:

https://ift.tt/3kVF2Dl

BONDS – NO TIME TO BUY

Bond markets, after a huge July rally, tumbled in September after hawkish turns from the U.S. Federal Reserve and the Bank of England, giving global government bond buyers a rare loss of 1%.

Clear third-quarter winners were inflation-linked bonds in the euro area and Britain, with returns of some 3% each, according to ICE BofA indexes. These securities are benefiting from fears that inflation spurred by supply-chain disruptions and labour shortages will be less transitory than flagged..

Globally there have now been more than 50 separate interest rate hikes this year, led by emerging market inflation hotspots like Brazil and Russia.

On credit markets, away from China’s turbulence, the lowest-rated “junk” euro corporate debt — at Triple C or lower — have returned around 1.4% as companies continue to recover from the pandemic.

For a graphic on Global FX year to date:

https://ift.tt/39PioGc

(Reporting by Marc Jones and Julien Ponthus; Additional reporting by Sujata Rao, Danilo Masoni and Yoruk Bahceli; Editing by Hugh Lawson)

Source Link Markets in Q3: Bears in the China shop

David Barret
David Barret

Related posts:

  1. Australia’s treasurer says economy must diversify from China reliance
  2. China Evergrande bonds suspended as prices slump
  3. At unfinished Evergrande apartments in central China, buyers seek answers
  4. U.S. sanctions several Hong Kong-based Chinese entities over Iran -website

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Trump Orders First Nuclear Weapons Test In The US Since 1992 – Here’s What You Need To Know
  • Tiny Triceratops-Tackling Tyrannosaur Was Its Own Species, Not A Baby T. Rex
  • What Makes Ammolite Gemstones, A Rare Kind Of Fossilized Ammonite, So Vibrant? It’s All In The Nacre
  • Something Melted This Tesla’s Windscreen. Could It Have Been A World-First Meteorite Collision?
  • Carnivorous “Death-Ball” Sponge Among 30 New Deep-Sea Weirdos Discovered In The Southern Ocean
  • Chimps Can Revise Beliefs When Confronted With Conflicting Evidence. Can You?
  • Explosive Airbursts, Like Tunguska, Might Be Hiding Among “Halloween Fireballs” Meteor Shower
  • One Of The World’s Rarest Penguins Is Actually Three Subspecies In A Trench Coat
  • “I Am The Allergen”: The Super-Rare Condition That Makes Everyone Else Allergic To You
  • 42,000-Year-Old Yellow Crayon Suggests Neanderthals Created Art – And It’s Still Sharp Too
  • IFLScience Investigates The Loch Ness Monster: A Round-Up Of Our Spooky Season Nessie Deep Dive
  • Why An Eastern Pacific Tear In Earth’s Crust Could Spare The Pacific Northwest… Eventually
  • JWST Reveals Never-Before-Seen Details Of The Red Spider Nebula And It’s Spectacular
  • “Breaking Records By Extraordinary Margins”: 22 Of Earth’s 34 Vital Signs At Record Levels
  • “The Most Important Unsolved Problem In Pure Math”: Where Is Humanity At With Prime Numbers?
  • The “Great Halloween Solar Storms”: 22 Years Ago, One Of The Most Powerful CMEs Ever Hit Earth
  • IFLScience Investigates The Loch Ness Monster: A Documentary On The Science, The Story, And The Power Of Belief
  • Remarkably Preserved 23-Million-Year-Old “Frosty” Rhino Discovered In Canadian Arctic
  • Want To “Time Travel” Back To Your Childhood? Baby Filter Image Illusion Could Unlock Lost Memories
  • The Sun Is Giving Us A Spooky Grimace Just In Time For Halloween
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version